Matteo Trotta joined Incyte as Executive Vice President and General Manager of U.S. Dermatology in 2024 overseeing the U.S. Dermatology Business Unit including commercial and medical affairs teams. Mr. Trotta has more than 15 years of pharmaceutical industry experience, spanning multiple therapeutic areas, clinical, platforms, functions and geographies. Prior to Incyte, Mr. Trotta served as the Head of Novartis U.S. Immunology, where he led a 400-person organization across dermatology, rheumatology, auto-inflammatory rare diseases and allergy. He additionally held leadership roles in U.S. marketing and sales, enterprise strategy and global manufacturing and quality. Before joining Novartis in 2012, he was an Engagement Manager at McKinsey & Company where he served pharmaceutical and payer clients as part of their healthcare practice and held roles at GM-FIAT Worldwide Purchasing. Mr. Trotta received his Engineering Degree from Politecnico di Torino, his Master of Science in Engineering from the University of Illinois Chicago and his Master of Business Administration from Columbia Business School.